Kailera Therapeutics Inc.
KLRA | NASDAQ
$12.92
+$0.06 (+0.47%)
Nov 2, 2026, 10:05 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Net Income | -148.96M |
Depreciation & Amortization | 310K |
Stock-Based Compensation | 10.94M |
Other Working Capital | 12.09M |
Other Non-Cash Items | 714K |
Deferred Income Tax | n/a |
Change in Working Capital | 16.78M |
Operating Cash Flow | -120.21M |
Capital Expenditures | -2.09M |
Cash Acquisitions | n/a |
Purchase of Investments | -632.16M |
Sales Maturities Of Investments | 141.65M |
Other Investing Acitivies | n/a |
Investing Cash Flow | -492.6M |
Debt Repayment | 100M |
Common Stock Repurchased | n/a |
Dividend Paid | n/a |
Other Financial Acitivies | -499.19M |
Financial Cash Flow | 598.66M |
Net Cash Flow | -14.15M |
Free Cash Flow | -122.3M |
Adj. Free Cash Flow | -133.24M |
Maintenance CapEx | -310K |
Growth CapEx | -1.78M |
Owner Earnings | -120.52M |
Add to Watchlist
Select watchlists to add or remove KLRA